Search
Showing results for "early lung health"
Research
The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocolCoronavirus-2019 (COVID-19) vaccination in Australia commenced in February 2021. The first vaccines recommended for use were AZD1222 and BNT162b2, both delivered as a two-dose primary schedule. In the absence of sustained immunity following immunisation, recommendations for booster vaccination have followed. It is likely that periodic boosting will be necessary for at least some Australians, but it is unknown what the optimal booster vaccines and schedules are or for whom vaccination should be recommended.
Research
Rheumatic Heart DiseaseRheumatic heart disease (RHD) is the most important cause of acquired cardiovascular disease in children and young adults. Virtually non-existent in most of Australia, it still predominantly affects Aboriginal communities.
Research
ImmunisationImmunisation is the most effective way of protecting your child against a range of serious illnesses, including measles, hepatitis B and whooping cough. All vaccines used in Australia undergo stringent testing and ongoing monitoring.

Research
Respiratory Syncytial Virus (RSV)RSV hospitalises millions of babies worldwide every year: our research is helping to change that.
These project websites display extended detailed information about specific research areas.
Research
Strep A (Group A Streptococcus)Streptococcus A is a bacterium often found in the throat and on the skin.

In 2020, we celebrated our 30th birthday with those who matter most — the kids whose lives we’ve changed through the research we do.